Product Images Mirtazapine

The text describes a table with age ranges and the difference in the number of cases of suicidality per 1000 patients treated with drugs compared to the placebo. It shows that for patients under 18 years old, there were 14 additional cases of suicidality with drug treatment compared to placebo. For patients between 18-24 years old, there were five additional cases. However, for patients between 25-64 years old, there was one fewer case with drug treatment compared to placebo, and for patients over 65 years old, there were six fewer cases.*

This is a table showing the percentage of patients discontinuing treatment due to adverse events for the antidepressant medication Mirtazapine compared to a placebo. The adverse events listed are somnolence (drowsiness) and nausea. For somnolence, 104% of Mirtazapine patients discontinued treatment due to this side effect compared to only 22% of placebo patients. For nausea, 15% of Mirtazapine patients discontinued treatment due to this side effect compared to 0% of placebo patients.*

This is a table that presents the percentage of patients reporting adverse events while taking Mirtazapine versus Placebo. The adverse events reported with Mirtazapine are Somnolence (54%), Increased Appetite (17%), Weight Gain (12%) and Dizziness (7%). Compared to Placebo, the incidence of Somnolence, Increased Appetite, Weight Gain, and Dizziness were higher with Mirtazapine.*

This appears to be a table listing adverse reactions experienced by patients taking Mirtazapine versus a placebo across various body systems. The table provides percentages of patients who experienced each adverse reaction. The adverse reactions are further categorized based on the body system affected such as body as a whole, digestive system, metabolic and nutritional disorders, musculoskeletal system, nervous system, respiratory system, and urogenital system.*

If you take Mirtazapine tablets, USP, you should not take any other medicines that contain mirtazapine including mirtazapine orally disintegrating tablets.*

This appears to be a prescription drug label for Mirtazapine, a medication used to treat depression. The label contains information about the manufacturer, dosage, lot number, and storage instructions for the drug. It also includes a warning that the drug should be dispensed only by prescription and kept in a light-resistant container.*